Today: 9 June 2026
Ares Management stock drops 3% in New York as Fed minutes hit year-end trading
30 December 2025
2 mins read

Ares Management stock drops 3% in New York as Fed minutes hit year-end trading

NEW YORK, December 30, 2025, 2:20 PM ET — Regular session

  • Ares Management shares fell about 3% in afternoon trade, underperforming major listed alternative-asset peers.
  • Investors digested fresh Federal Reserve minutes that highlighted divisions over the path for rate cuts.
  • A Reuters Breakingviews column flagged shrinking yield advantages in private credit, a key business line for Ares.

Shares of Ares Management Corp fell 3.1% to $163.85 in afternoon trading on Tuesday, down $5.20 from Monday’s close. The stock traded between $168.99 and $163.49, with about 966,000 shares changing hands.

The move matters because Ares is closely tied to credit-market conditions. Investors are weighing where interest rates settle in early 2026 and what that means for fundraising, deal activity and returns in private credit.

A Reuters Breakingviews column said private credit is losing some of its pricing edge as bank-led bond and loan markets regain momentum, pushing terms closer together. It also said the yield premium — the extra return private loans offer over comparable public-market debt — has narrowed, a dynamic that can pressure returns across the roughly $2 trillion private credit market.

Fresh Federal Reserve minutes released Tuesday showed policymakers were split at the December 9–10 meeting, with some officials calling the decision to cut rates “finely balanced.” The quarter-point cut lowered the benchmark rate to a 3.5%–3.75% range, and the minutes pointed to debate over how long to hold rates steady as inflation progress has been uneven; the Fed’s next meeting is Jan. 27–28, with key U.S. jobs and inflation reports due Jan. 9 and Jan. 13. Reuters

U.S. stocks were muted in thin, holiday-truncated trade, with declines in financials offsetting strength elsewhere. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide. Reuters

Ares’ drop stood out against other big listed alternative-asset managers, which were little changed to modestly lower: Blackstone was flat, while Apollo, KKR and Carlyle were down around half a percent or less.

Private credit refers to loans made outside public bond and syndicated loan markets, often directly to companies, typically with fewer intermediaries. Investors focus on the “spread,” or extra compensation, because it helps determine whether private loans still pay enough to justify their lower liquidity.

A narrower premium tends to squeeze returns unless managers can protect deal terms, lower funding costs or move into higher-margin strategies. For Ares, that puts a premium on maintaining asset growth and performance as competition increases.

Rate expectations add another layer. Lower policy rates can boost refinancing and deal activity, but they also reduce coupons on many floating-rate loans, which can dampen income unless credit spreads widen or leverage rises.

Traders will also watch whether the Fed’s internal divisions translate into a longer pause on cuts, which can keep borrowing costs elevated and affect valuations for credit-heavy assets. The tone of January’s data releases will be a key near-term driver for rate-sensitive financial stocks.

In the near term, investors will be looking for signs that private credit can hold pricing power as banks compete more aggressively for deals. They will also be monitoring fund flows into private-market products and any read-through from credit issuance into fee growth expectations for asset managers.

Stock Market Today

  • How Teens Can Use Summer Jobs to Build $500,000 in Savings
    June 9, 2026, 10:39 AM EDT. Teenagers who take on summer jobs gain more than just work experience-they acquire critical financial skills and early capital to invest. Starting to invest money earned from summer jobs during teenage years can significantly boost savings over time. Leveraging compound interest, teens can potentially accumulate up to $500,000 or more by adulthood. Experts emphasize the importance of early saving and investing to maximize growth. Those who skip summer jobs miss out on this critical opportunity to build a robust financial foundation for their future.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop